WOUND STICK

• US 20110125109A1
• Filed: 11/10/2010
• Published: 05/26/2011
• Est. Priority Date: 11/10/2009
• Status: Abandoned Application

• Current Assignee: Erik B. Young
• Original Assignee: Erik B. Young
• Inventors: Young, Erik B.
• Application Number:
  US12/943,396
• Publication Number:
  US 20110125109A1
• Time in Patent Office: Days
• US Class Current: 604/286
• CPC Class Codes: A61K 31/00 Medicinal preparations containing organic active ingredients
• CPC Class Codes: A61K 45/06 Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
• CPC Class Codes: A61K 9/06 Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels composition of ointments, creams or gels A61K47/00
• CPC Class Codes: A61K 9/122 Foams; Dry foams edible foams A61K9/0056
• CPC Class Codes: A61K 9/7007 Drug-containing films, membranes or sheets A61K9/0041, A61K9/0043, A61K9/006, A61K9/0063 take precedence
• CPC Class Codes: A61P 7/04 Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents

Abstract

A device for introducing a haemostatic agent into a penetrating wound. The device includes an elongate introducing member and a haemostatic agent applied to the elongate introducing member. The haemostatic agent may be applied to the introducing member using a flexible membrane, configured to be rolled around the elongate introducing member, a biocompatible foam, or a gel.

Claims

1. A device, comprising:

an elongate introducing member; and

a haemostatic agent applied to the elongate introducing member.

2. The device according to claim 1, wherein the haemostatic agent comprises a coagulant or a combination of several coagulants.

3. The device according to claim 2, wherein the haemostatic agent further comprises an absorbent agent.

4. The device according to claim 1, wherein the elongate introducing member comprises an elongate center shaft, the haemostatic agent being disposed such that the haemostatic agent surrounds the elongate center shaft.

5. The device according to claim 1, wherein the elongate introducing member comprises a smooth tapered end.

6. A device, comprising:

an elongate introducing member;

a flexible and permeable or perforated membrane configured to be rolled around the elongate introducing member; and

a haemostatic agent rolled within or disposed on the membrane.

7. The device according to claim 6, wherein the flexible and permeable or perforated membrane comprises a thin film having a plurality of perforations disposed in an array on the flexible and permeable or perforated membrane.

8. The device according to claim 6, wherein the haemostatic agent is disposed on at least one surface of the flexible and permeable or perforated membrane.

9. The device according to claim 6, wherein the haemostatic agent is disposed between layers of the flexible and permeable or perforated membrane when the membrane is rolled around the elongate introducing member.

10. The device according to claim 6, wherein the haemostatic agent is chemically or physically bound to at least surface of the flexible and permeable or perforated membrane.

11. The device according to claim 6, wherein the haemostatic agent comprises a coagulant or a combination of several coagulants.

12. The device according to claim 11, wherein the haemostatic agent further comprises an absorbent agent.

13. A device, comprising:

an elongate introducing member; and

a material surrounding the elongate introducing member, the material being impregnated with a haemostatic agent.

14. The device according to claim 13, wherein the material comprises a compressed, biocompatible, foam cylinder surrounding the elongate introducing member.

15. The device according to claim 13, wherein the material comprises a semi-rigid gel surrounding the elongate introducing member.

16. The device according to claim 13, further comprising a removable sheath disposed around the material.

17. The device according to claim 13, wherein the haemostatic agent comprises a coagulant or a combination of several coagulants.

18. The device according to claim 17, wherein the haemostatic agent further comprises an absorbent agent.